Olivier Michielin
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment.
Garbe C, Keim U, Amaral T, Berking C, Eigentler T, Flatz L, Gesierich A, Leiter U, Stadler R, Sunderkötter C, Tüting T, Utikal J, Wollina U, Zimmer L, Zouboulis C, Ascierto P, Eggermont A, Grob J, Hauschild A, Sekulovic L, Long G, Luke J, Michielin O, Peris K, Schadendorf D, Kirkwood J, Lorigan P, Central Malignant Melanoma Registry (CMMR). Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment. J Clin Oncol 2022; 40:3741-3749.
16.06.2022Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment.
16.06.2022J Clin Oncol 2022; 40:3741-3749
Garbe Claus, Keim Ulrike, Amaral Teresa, Berking Carola, Eigentler Thomas Kurt, Flatz Lukas, Gesierich Anja, Leiter Ulrike, Stadler Rudolf, Sunderkötter Cord, Tüting Thomas, Utikal Jochen, Wollina Uwe, Zimmer Lisa, Zouboulis Christos C, Ascierto Paolo Antonio, Eggermont Alexander M M, Grob Jean-Jacques, Hauschild Axel, Sekulovic Lidija Kandolf, Long Georgina V, Luke Jason J, Michielin Olivier, Peris Ketty, Schadendorf Dirk, Kirkwood John M, Lorigan Paul C, Central Malignant Melanoma Registry (CMMR)
Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA).
Jörger M, Metaxas Y, Zaman K, Michielin O, Mach N, Bettini A, Schmitt A, Cantoni N, Caspar C, Stettler S, Malval R, Pless M, Britschgi C, Renner C, Koeberle D, Schulz J, Kopp C, Hayoz S, Stathis A, von Moos R, Swiss Group for Clinical Cancer Research (SAKK). Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA). Cancers (Basel) 2022; 14
27.04.2022Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA).
27.04.2022Cancers (Basel) 2022; 14
Jörger Markus, Metaxas Yannis, Zaman Khalil, Michielin Olivier, Mach Nicolas, Bettini Adrienne, Schmitt Andreas M, Cantoni Nathan, Caspar Clemens B, Stettler Sonja, Malval Roma, Pless Miklos, Britschgi Christian, Renner Christoph, Koeberle Dieter, Schulz Jessica D, Kopp Christoph, Hayoz Stefanie, Stathis Anastasios, von Moos Roger, Swiss Group for Clinical Cancer Research (SAKK)
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
Kunstfeld R, Moser E, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori F, Pfeilstöcker M, Raut C, Michielin O, Meran J, Lenz H, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer P, Markham M, Markman B, Mayerhoefer M, Remick S, Robson M, Rutkowski P, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber J, Wildiers H, Strasser F, Stiefel F, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll H, Schnipper L, Sessa C, Shapiro C, Steele J, Sternberg C, Yarden Y, Dittrich C, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close J, Coiffier B, Connolly R, Coupland S, Banerjee S, Awada A, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz J, Österlund P, Pavlidis N, Purkalne G, De Petris L, De Santis M, de Vries E, Hahn S, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones D, Jost L, Keilholz U, Khan S, Kiss A, Grothey A, Gopalan P, Dizon D, Duff J, Duska L, Eniu A, Ernstoff M, Felip E, Fey M, Gilbert J, Girard N, Glaudemans A, Köhne C. ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open 2016; 1:e000097.
29.09.2016ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
29.09.2016ESMO Open 2016; 1:e000097
Kunstfeld Rainer, Moser Elizabeth Charlotte, Mountzios Giannis, Moynihan Timothy, Nielsen Torsten, Ohe Yuichiro, Öberg Kjell, Palumbo Antonio, Peccatori Fedro Alessandro, Pfeilstöcker Michael, Raut Chandrajit, Michielin Olivier, Meran Johannes G, Lenz Heinz-Josef, Lichtman Stuart, Licitra Lisa, Lion Thomas, Litière Saskia, Liu Lifang, Loehrer Patrick J, Markham Merry Jennifer, Markman Ben, Mayerhoefer Marius, Remick Scot C, Robson Mark, Rutkowski Piotr, Stupp Roger, Sullivan Richard, Tabernero Josep, Travado Luzia, Verheij Marcel, Voest Emile, Vokes Everett, Von Roenn Jamie, Weber Jeffrey S, Wildiers Hans, Strasser Florian, Stiefel Friedrich, Salgado Roberto, Schapira Lidia, Schernhammer Eva, Schlumberger Martin, Schmoll Hans-Joachim, Schnipper Lowell, Sessa Cristiana, Shapiro Charles L, Steele Julie, Sternberg Cora N, Yarden Yosef, Dittrich Christian, Bhatia Smita, Bogaerts Jan, Buckner Jan, Cardoso Fatima, Casali Paolo, Chu Edward, Close Julia Lee, Coiffier Bertrand, Connolly Roisin, Coupland Sarah, Banerjee Susana, Awada Ahmad, Kosty Michael, Jezdic Svetlana, Pyle Doug, Berardi Rossana, Bergh Jonas, El-Saghir Nagi, Lotz Jean-Pierre, Österlund Pia, Pavlidis Nicholas, Purkalne Gunta, De Petris Luigi, De Santis Maria, de Vries Elisabeth G E, Hahn Stephen M, Hanna Diana, Herold Christian, Herrstedt Jørn, Homicsko Krisztian, Jones Dennie V, Jost Lorenz, Keilholz Ulrich, Khan Saad, Kiss Alexander, Grothey Axel, Gopalan Priya K, Dizon Don S, Duff Jennifer, Duska Linda R, Eniu Alexandru, Ernstoff Marc, Felip Enriqueta, Fey Martin F, Gilbert Jill, Girard Nicolas, Glaudemans Andor W J M, Köhne Claus-Henning
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
Demaria O, Speiser D, Modlin R, Martinon F, Petrova T, Hwu P, Michielin O, Gaide O, Flatz L, Di Domizio J, Gestermann N, Coso S, De Gassart A, Gilliet M. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. Proc Natl Acad Sci USA 2015; 112:15408-13.
25.11.2015STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
25.11.2015Proc Natl Acad Sci USA 2015; 112:15408-13
Demaria Olivier, Speiser Daniel E, Modlin Robert L, Martinon Fabio, Petrova Tatiana V, Hwu Patrick, Michielin Olivier, Gaide Olivier, Flatz Lukas, Di Domizio Jeremy, Gestermann Nicolas, Coso Sanja, De Gassart Aude, Gilliet Michel
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
Schraml P, Moch H, Schläppi M, Seifert B, Michielin O, Dummer R, Ochsenbein A, Simcock M, Mihic-Probst D, von Teichman A, von Moos R. Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07. Oncol Rep 2012
18.05.2012Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
18.05.2012Oncol Rep 2012
Schraml Peter, Moch Holger, Schläppi Marc, Seifert Bettina, Michielin Olivier, Dummer Reinhard, Ochsenbein Adrian, Simcock Mathew, Mihic-Probst Daniela, von Teichman Adriana, von Moos Roger